Target intelligence / Profile preview

Ocular surface mucin layer and epithelial glycocalyx

Molecular classification
Other
01

Overview

The **ocular surface mucin layer and epithelial glycocalyx** are not a single molecule or receptor, but together they constitute a critical *biophysical and biochemical interface* between the ocular surface epithelial cells (mainly conjunctival and corneal) and the tear film[4][5][6][7]. - **Membrane-associated mucins** (notably MUC1, MUC4, and MUC16) are heavily glycosylated proteins expressed on the apical surface of ocular epithelial cells, forming a dense *glycocalyx* that provides a barrier against pathogens, reduces friction, and maintains surface wettability[4][7]. - **Secreted gel-forming mucins** (notably MUC5AC, produced by goblet cells) contribute to the tear film's muco-aqueous layer, trapping debris and pathogens, providing lubrication, and facilitating clearance of foreign material[1][2][3][4]. These mucins are central to ocular surface integrity, lubrication, and defense. Alterations in either mucin production or the epithelial glycocalyx are strongly linked to dry eye disease, allergy, and infection[1][2][4][6]. Both are essential therapeutic targets *indirectly* in ophthalmology, but are not a single, druggable receptor, enzyme, or discrete molecular target.

Other names
Ocular mucins layerOcular surface mucinsMucin layer of tear filmOcular epithelial glycocalyx
02

Mechanism of action

Indirect modulation of mucin gene expression and secretion; improvement of goblet cell function and epithelial health

03

Biological functions

Lubrication of the ocular surfaceBarrier function (preventing pathogen penetration)Maintenance of tear film stability and wettabilityClearing of debris and pathogensCell signaling (proposed)Reduction of friction during blinking
04

Disease associations

Dry eye diseaseOcular surface inflammation and allergyOcular surface infectionAutoimmune ocular surface disease
05

Safety considerations

Insufficient restoration of mucin/epithelial glycocalyx in severe diseasePotential disruption of mucin or glycocalyx with prolonged preservative use in eye drops
06

Interacting drugs

Cyclosporine

2 more in the full profile.

07

Biomarkers

Levels of MUC5AC and related mucins in the tear filmGoblet cell density in conjunctiva

Beyond the preview

Go deeper on Ocular surface mucin layer and epithelial glycocalyx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface mucin layer and epithelial glycocalyx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call